ANGELA REEVES: Open Payments
NPI 1760516413 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,286 in 75 payments from 24 companies in 2025. Trend: 2023 $999 · 2024 $1,062 · 2025 $1,286
Food & beverage: $1,286
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $295 |
| AstraZeneca Pharmaceuticals LP | 7 | $187 |
| Novo Nordisk Inc | 10 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Eisai Inc. | 2 | $53 |
| Lundbeck LLC | 2 | $52 |
| Medtronic, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $34 |
Products named: UBRELVY, AIRSUPRA, VRAYLAR, XIFAXAN, Ozempic, Kerendia, CAPLYTA, Leqembi.
Industry payments across SC — which companies pay providers there.
